Protecting Patients With Cirrhosis From Coronavirus Disease 2019: Identifying Gaps in Vaccination Rates.
作者信息
Goldberg David S, Wolfe Cameron R, Brown Robert S, Verna Elizabeth C
机构信息
Division of Digestive Health and Liver DiseasesDepartment of Medicine University of Miami Miller School of Medicine Miami FL Division of Infectious DiseasesDepartment of Medicine Duke University Durham NC Division of Gastroenterology and Hepatology Weill Cornell Medicine New York NY Division of Digestive and Liver Diseases Columbia University Vagelos College of Physicians and Surgeons New York NY.
出版信息
Liver Transpl. 2021 Nov;27(11):1535-1537. doi: 10.1002/lt.26305. Epub 2021 Oct 5.
Abstract
摘要
相似文献
1
Protecting Patients With Cirrhosis From Coronavirus Disease 2019: Identifying Gaps in Vaccination Rates.保护肝硬化患者免受2019冠状病毒病侵害：识别疫苗接种率方面的差距。
Liver Transpl. 2021 Nov;27(11):1535-1537. doi: 10.1002/lt.26305. Epub 2021 Oct 5.
2
Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID-19: A Multicenter Cohort.无论是否感染新冠病毒，肝硬化都与90天内的高死亡率和再入院率相关：一项多中心队列研究
Liver Transpl. 2021 Sep;27(9):1343-1347. doi: 10.1002/lt.25981. Epub 2021 Mar 15.
3
COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.失代偿期肝硬化患者的 COVID-19 疫苗：一项回顾性队列研究，评估安全性数据和与未接种状态相关的风险因素。
Infect Dis Poverty. 2022 May 16;11(1):56. doi: 10.1186/s40249-022-00982-0.
4
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.肝移植受者和慢性肝病患者接种新冠疫苗后的抗体反应分析。
J Hepatol. 2021 Dec;75(6):1434-1439. doi: 10.1016/j.jhep.2021.08.008. Epub 2021 Aug 26.
5
High rates of 30-day mortality in patients with cirrhosis and COVID-19.肝硬化合并 COVID-19 患者的 30 天死亡率较高。
J Hepatol. 2020 Nov;73(5):1063-1071. doi: 10.1016/j.jhep.2020.06.001. Epub 2020 Jun 9.
6
Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work?2019冠状病毒病（COVID-19）在肝硬化患者中的疫苗接种：有效吗？
Hepatol Commun. 2022 Jun;6(6):1502-1503. doi: 10.1002/hep4.1931. Epub 2022 Apr 16.
7
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients.肝硬化和肝移植患者第二次接种后针对 SARS-CoV2 的体液和 T 细胞免疫应答。
Clin Gastroenterol Hepatol. 2022 Jan;20(1):162-172.e9. doi: 10.1016/j.cgh.2021.09.003. Epub 2021 Sep 9.
8
[Rapid guideline for COVID-19 vaccination in patients with chronic liver diseases, hepatolbiliary malignancy and liver transplant].[慢性肝病、肝胆恶性肿瘤及肝移植患者COVID-19疫苗接种快速指南]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):523-526. doi: 10.3760/cma.j.cn501113-20210612-00278.
9
Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.2020 年法国慢性肝病 COVID-19 患者预后的全国回顾性队列研究。
J Hepatol. 2021 Oct;75(4):848-855. doi: 10.1016/j.jhep.2021.04.052. Epub 2021 May 14.
10
Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic.美国慢性肝病和肝硬化患者的死亡率趋势：新冠疫情之前和期间的情况。
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2664-2666.e2. doi: 10.1016/j.cgh.2021.07.009. Epub 2021 Jul 10.
Zotero 插件